| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BELANOFF JOSEPH K | Chief Executive Officer, Director | C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY | /s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff. | 2025-05-05 | 0001286199 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Common Stock | Sale | -$1.34M | -18.5K | -0.62% | $72.52 | 2.96M | May 2, 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F2, F3 |
| transaction | CORT | Common Stock | Sale | -$1.58M | -21.5K | -0.73% | $73.22 | 2.94M | May 2, 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction. |
| F2 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.13 to $72.99 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F3 | Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| F4 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.00 to $73.65 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
The power of attorney under which this form was signed is on file with the Commission.